Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Financial Results

📢 Key Event
Trading window closure announced for designated persons

💡 Investor Takeaway
Trading restrictions apply until results are declared.

Jagsonpal Pharmaceuticals announced that its trading window closes on July 1, 2026, ahead of unaudited Q1 results, with board meeting date to be disclosed later.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,384.48 Cr P/E: 32.1

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

💡 Ask AI about this filing

"How does this affect JAGSNPHARM margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

🔥 Also filed on 26 June 2026

NRL Nupur Recyclers Limited Insider Trading BBL Bharat Bijlee Limited Annual Report BIRLACORPN Birla Corporation Limited Corporate Action BRIGADE Brigade Enterprises Limited Announcement NTPC NTPC Limited Announcement TTKPRESTIG TTK Prestige Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day